BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12458653)

  • 1. Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications.
    Neutel JM; Klein C; Meinicke TW; Schumacher H
    Blood Press; 2002; 11(5):302-9. PubMed ID: 12458653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB; Reilly PA
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension.
    McGill JB; Reilly PA
    Clin Cardiol; 2001 Jan; 24(1):66-72. PubMed ID: 11195609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan/hydrochlorothiazide combination therapy in the treatment of essential hypertension.
    Schmieder RE
    Expert Opin Pharmacother; 2004 Nov; 5(11):2303-10. PubMed ID: 15500377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
    Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L
    Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.
    Freytag F; Schelling A; Meinicke T; Deichsel G;
    Clin Ther; 2001 Jan; 23(1):108-23. PubMed ID: 11219471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
    Oparil S; Aurup P; Snavely D; Goldberg A
    Am J Cardiol; 2001 Mar; 87(6):721-6. PubMed ID: 11249890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication.
    Neldam S; Edwards C
    Expert Opin Pharmacother; 2009 Feb; 10(3):345-52. PubMed ID: 19191674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term exposure to telmisartan as monotherapy or combination therapy: efficacy and safety.
    Freytag F; Holwerda NJ; Karlberg BE; Meinicke TW; Schumacher H
    Blood Press; 2002; 11(3):173-81. PubMed ID: 12126264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension.
    Neutel JM; Frishman WH; Oparil S; Papademitriou V; Guthrie G
    Am J Ther; 1999 May; 6(3):161-6. PubMed ID: 10423659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
    Manolis AJ; Reid JL; de Zeeuw D; Murphy MB; Seewaldt-Becker E; Köster J;
    J Hypertens; 2004 May; 22(5):1033-7. PubMed ID: 15097245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy.
    Lacourcière Y; Tytus R; O'Keefe D; Lenis J; Orchard R; Martin K
    J Hum Hypertens; 2001 Nov; 15(11):763-70. PubMed ID: 11687919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan plus HCTZ vs. amlodipine plus HCTZ in older patients with systolic hypertension: results from a large ambulatory blood pressure monitoring study.
    Neldam S; Edwards C;
    Am J Geriatr Cardiol; 2006; 15(3):151-60. PubMed ID: 16687967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension.
    Mallion J; Siche J; Lacourcière Y
    J Hum Hypertens; 1999 Oct; 13(10):657-64. PubMed ID: 10516734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.
    Oparil S; Abate N; Chen E; Creager MA; Galet V; Jia G; Julius S; Lerman A; Lyle PA; Pool J; Tershakovec AM
    Curr Med Res Opin; 2008 Apr; 24(4):1101-14. PubMed ID: 18328120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
    Weir MR; Elkins M; Liss C; Vrecenak AJ; Barr E; Edelman JM
    Clin Ther; 1996; 18(3):411-28. PubMed ID: 8829017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Freehand three-dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-to-moderate hypertension: a multicentre study.
    Galzerano D; Tammaro P; Cerciello A; Breglio R; Mallardo M; Lama D; Tuccillo B; Capogrosso P
    J Hum Hypertens; 2004 Jan; 18(1):53-9. PubMed ID: 14688811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan/hydrochlorothiazide: in the treatment of essential hypertension.
    Fenton C; Keating GM; Scott LJ
    Drugs; 2003; 63(19):2013-26; discussion 2027-8. PubMed ID: 12962518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.